Vanguard Group Inc. Grows Position in Agios Pharmaceuticals, Inc. (NASDAQ:AGIO)
Vanguard Group Inc. raised its position in Agios Pharmaceuticals, Inc. (NASDAQ:AGIO – Free Report) by 1.5% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 5,631,321 shares of the biopharmaceutical company’s stock after buying an additional 85,339 shares during the […]
Vanguard Group Inc. raised its position in Agios Pharmaceuticals, Inc. (NASDAQ:AGIO – Free Report) by 1.5% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 5,631,321 shares of the biopharmaceutical company’s stock after buying an additional 85,339 shares during the […]
